Z-0809-05
Nichols IRMA Intact PTH Assay, catalog No. 40-2171
Nichols Institute Diagnostics / initiated 2005-03-25 / Terminated / root cause: labeling and UDI
Nichols Institute Diagnostics began a recall of Nichols IRMA Intact PTH Assay, catalog No. 40-2171 on . The reason FDA records is "Firm noted a change in performance and therefore changed the labeled performance specifications in the Directional Insert portion of the labeling". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-0809-05
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Nichols Institute Diagnostics
- Product
- Nichols IRMA Intact PTH Assay, catalog No. 40-2171
- Product code
- CEW Radioimmunoassay, Parathyroid Hormone
- Reason for recall
- Firm noted a change in performance and therefore changed the labeled performance specifications in the Directional Insert portion of the labeling.
- Root cause tag
- labeling and UDI
- FDA root cause
- Other
- Action
- Firm sent customer notifications to firms on March 9 and 11, 2005 which were deemed not appropriate upon review by the FDA, firm agreed to resend notices approved by FDA on March 25, 2005 which requested that customers cease using the lots and destroy inventory for credit.
- Quantity in commerce
- Not divulged
- Distribution
- Nationwide, Canada, Greece, Italy, Sweden, Austria, Balgium, Korea, Spain, Grea Britian, Taiwan, Finland, Denmark, New Zealand, Israel
- Product codes and lots
- Lots 40-504553/4 released March 4, 2005 and kit lots 40-501687/8 released March 18, 2005
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
